That shift matters in medico-legal reporting. A claimant does not need to stop travelling completely before post-accident anxiety becomes functionally significant.
Travel anxiety is not simply PTSD.
One of the most persistent mistakes is treating anxiety about driving as shorthand for post-traumatic stress disorder.
PTSD can certainly follow a serious accident. NICE identifies serious accidents as events capable of causing PTSD and advises assessment for symptoms including re-experiencing, avoidance, hyperarousal and associated functional impairment, a claimant may experience substantial travel anxiety without meeting the diagnostic criteria for PTSD.
They may be comfortable in most areas of life but unable to drive on motorways. Another claimant may drive but refuse to travel as a passenger because being unable to control the vehicle produces intense anxiety. Others avoid the location of the accident, become distressed around large vehicles or restrict journeys to familiar roads.
This distinction is not new. An Oxford follow-up study of road traffic accident victims published in the 1990s found that phobic travel anxiety as a driver or passenger could be frequent and disabling, including in people who did not necessarily have PTSD. What is developing is a better appreciation of travel restriction as an outcome.
Researchers are looking beyond symptoms.
A 2025 study from the University of California Institute of Transportation Studies examined how collision experiences affected subsequent perceptions of road safety and travel behaviour.
Participants described changing their mode of travel, travelling less frequently, altering the purpose of journeys and changing the type of vehicle they used. Long-term effects included fear, behavioural modification and avoidance of travel.
The study was qualitative and based on focus groups, so it should not be used to estimate how common these effects are among all accident victims. Its value lies elsewhere. It demonstrates why medico-legal assessment should ask more than, “Are you anxious when travelling?”
Has the claimant stopped driving at night? Do they avoid motorways? Have they become dependent on a partner for journeys? Are they taking public transport rather than driving? Have they declined social activities or employment because travelling there feels unsafe? Two claimants may both describe moderate anxiety while experiencing very different levels of functional restriction.
Pre-accident vulnerability is receiving more attention.
Another emerging theme is that psychological outcome cannot be understood solely by examining the severity of the collision.
A 2025 retrospective study examining anxiety and depression after road crashes found relationships involving crash severity, physical health and pre-crash psychological factors. Pre-crash anxiety and depression formed part of the pattern influencing later psychological outcomes, this is important medico-legally.
The presence of earlier anxiety does not mean that post-accident travel symptoms are unrelated to the collision. Equally, an accident occurring before the onset of travel anxiety does not prove that it was the sole cause.
Was the claimant previously a confident driver? Did they already avoid motorways, tunnels or unfamiliar routes? Had they experienced panic attacks while travelling? Was there a previous collision? Were they receiving treatment for anxiety before the index accident? The correct opinion may sometimes be aggravation rather than entirely new psychological injury.
Avoidance may become part of the maintenance cycle.
One of the clinically noteworthy features of travel anxiety is avoidance. Immediately after a frightening collision, reluctance to drive may be understandable. Most early psychological reactions following trauma do not develop into persistent PTSD, and NICE recognises that symptoms may occur in the first weeks after a traumatic event without becoming a continuing disorder, difficulties arise when avoidance becomes established.
A claimant who stops motorway driving experiences immediate relief from anxiety. That relief can make avoidance more likely next time. Journeys may then become increasingly restricted: motorway driving becomes dual carriageways, then unfamiliar roads, then driving altogether.
The expert should therefore examine trajectory rather than merely duration. Is the claimant gradually doing more, remaining static or becoming progressively more restricted? That question may tell us more about prognosis than the statement that anxiety has persisted for six months.
Treatment research remains less developed than it should be.
For a symptom with potentially substantial effects on independence and employment, the treatment evidence specific to post-accident travel anxiety remains surprisingly limited.
One study of 184 patients referred with travel phobia or milder accident-related travel anxiety examined trauma-focused cognitive behavioural therapy and EMDR. Both treatment groups showed improvement across psychological measures and return to driving or travelling, although the study was non-randomised and cannot establish that one treatment was superior to the other.
The broader evidence for PTSD treatment is stronger than the specific research into isolated travel anxiety. That distinction should be maintained.
It is also a reminder that treatment recommendations should follow diagnosis. A claimant with full PTSD, intrusive memories and hyperarousal may require a different programme from someone whose principal problem is a circumscribed fear of motorway driving.
Exposure to feared situations may form part of treatment but simply telling a claimant to “start driving again” is not a psychological rehabilitation plan.
Normal caution should not be medicalised.
Research into post-collision behaviour creates another risk: ordinary caution may be interpreted as psychological injury.
After a serious collision, a driver may become more attentive at junctions, maintain greater distances or avoid a particularly difficult road temporarily. The 2025 transportation research found that participants reported greater awareness of unsafe road-user behaviour and adopted more cautious attitudes after collisions. Not every behavioural change is pathological.
The medico-legal question is whether the response has become disproportionate, persistent and functionally restrictive.
Someone who prefers a different route but continues to work, socialise and travel independently presents differently from a claimant who can no longer drive to work or tolerate being a passenger. Diagnosis and disability should not be inferred from caution alone.
The research gap itself matters.
Recent systematic reviews confirm that psychological consequences following road traffic accidents extend well beyond physical injury, with PTSD, anxiety and depression repeatedly identified among survivors. At the same time, studies report substantial differences according to methodology, populations and assessment tools.
Travel-specific anxiety remains less standardised, that creates a medico-legal problem. Reports can become inconsistent because one expert treats reluctance to drive as a minor symptom while another regards similar behaviour as evidence of substantial psychiatric injury.
A better assessment starts with function.
The expert should establish the claimant’s pre-accident travel pattern, the precise situations now causing anxiety, journeys being avoided, whether the claimant can travel as a passenger, the effect on work and social activity, and whether restrictions are improving or spreading.
The emerging research is moving in the same direction. The important outcome is not simply whether anxiety exists. It is how an accident changes mobility.
For medico-legal experts, that is the more useful question. Travel anxiety becomes significant when fear does not merely accompany the journey, but begins determining where the claimant can go, how they get there and what parts of ordinary life they can still reach.
